Barclays
GTHX

Barclays’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-23,032
Closed -$53K 4503
2024
Q2
$53K Buy
23,032
+16,730
+265% +$38.5K ﹤0.01% 3659
2024
Q1
$27K Hold
6,302
﹤0.01% 3921
2023
Q4
$19K Hold
6,302
﹤0.01% 3979
2023
Q3
$9K Hold
6,302
﹤0.01% 4050
2023
Q2
$16K Sell
6,302
-2,463
-28% -$6.25K ﹤0.01% 4008
2023
Q1
$23K Sell
8,765
-17,710
-67% -$46.5K ﹤0.01% 3969
2022
Q4
$144K Sell
26,475
-87,156
-77% -$474K ﹤0.01% 3268
2022
Q3
$1.42M Buy
+113,631
New +$1.42M ﹤0.01% 1879
2022
Q2
Sell
-224
Closed -$2K 4974
2022
Q1
$2K Sell
224
-65,289
-100% -$583K ﹤0.01% 4680
2021
Q4
$669K Buy
65,513
+48,788
+292% +$498K ﹤0.01% 2394
2021
Q3
$224K Buy
16,725
+16,628
+17,142% +$223K ﹤0.01% 2926
2021
Q2
$2K Sell
97
-237
-71% -$4.89K ﹤0.01% 4024
2021
Q1
$8K Sell
334
-91,818
-100% -$2.2M ﹤0.01% 3737
2020
Q4
$1.66M Buy
92,152
+72,854
+378% +$1.31M ﹤0.01% 1693
2020
Q3
$222K Sell
19,298
-4,606
-19% -$53K ﹤0.01% 2688
2020
Q2
$579K Buy
23,904
+19,142
+402% +$464K ﹤0.01% 2255
2020
Q1
$52K Sell
4,762
-38,110
-89% -$416K ﹤0.01% 3088
2019
Q4
$1.13M Buy
42,872
+37,531
+703% +$992K ﹤0.01% 2219
2019
Q3
$122K Sell
5,341
-20,382
-79% -$466K ﹤0.01% 3299
2019
Q2
$789K Buy
25,723
+19,602
+320% +$601K ﹤0.01% 2483
2019
Q1
$101K Buy
6,121
+3,266
+114% +$53.9K ﹤0.01% 3334
2018
Q4
$55K Sell
2,855
-17,515
-86% -$337K ﹤0.01% 3148
2018
Q3
$1.07M Buy
20,370
+16,703
+455% +$873K ﹤0.01% 2215
2018
Q2
$159K Buy
3,667
+319
+10% +$13.8K ﹤0.01% 2859
2018
Q1
$124K Sell
3,348
-729
-18% -$27K ﹤0.01% 3077
2017
Q4
$81K Sell
4,077
-642
-14% -$12.8K ﹤0.01% 3111
2017
Q3
$118K Buy
4,719
+3,919
+490% +$98K ﹤0.01% 2638
2017
Q2
$14K Buy
+800
New +$14K ﹤0.01% 3364